Danish pharmaceutical giant has been steadily expanding its presence in India, and the arrival of Ozempic marks a significant move in a country grappling with fast-rising rates of type 2 diabetes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback